| |
 |
|
|
Inventor: Beattie; David
Address: Horsham, GB
No. of patents: 8
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 8283362 |
Beta-2-adrenoreceptor agonists |
October 9, 2012 |
| Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, |
| 8273900 |
Organic compounds |
September 25, 2012 |
| There are described cyclohexyl amide derivatives useful as corticotropin releasing factor (CRF.sub.1) receptor antagonists. |
| 8067437 |
Beta-2-adrenoreceptor agonists |
November 29, 2011 |
| Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, |
| 7820694 |
Beta-2-adrenoreceptor agonists |
October 26, 2010 |
| Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, |
| 7745462 |
Quinoline-2-one derivatives for the treatment of airways diseases |
June 29, 2010 |
| Compounds of formula I ##STR00001## in free or salt form, wherein --C--Y--, R.sup.1 and R.sup.2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the .beta..sub.2-adrenoreceptor. Pharmaceut |
| 7622483 |
.beta.2-adrenoceptor agonists |
November 24, 2009 |
| Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, |
| 6921757 |
Organic compounds |
July 26, 2005 |
| Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals ##STR1## |
| 6878721 |
Beta2-adrenoceptor agonists |
April 12, 2005 |
| Compounds of formula ##STR1##in free or salt or solvate form, where Ar is a group of formula ##STR2##Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their p |
|
|
|
